Arcutis Biotherapeutics, Inc. ARQT Intangible Amortization
Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s intangible amortization?
- Arcutis Biotherapeutics, Inc. (ARQT) reported intangible amortization of $562K in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s intangible amortization changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s intangible amortization decreased by 81.1% year-over-year, from $2.98M to $562K.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s intangible amortization?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s intangible amortization has grown at a 146.4% compound annual growth rate (CAGR), from $312K to $4.67M.
- What does intangible amortization mean?
- Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.